Vallon Pharmaceuticals Inc VLON:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/21/22 EST
4.77UNCH (UNCH)
Volume
570
Close
4.77quote price arrow down-0.20 (-4.02%)
Volume
74,630
52 week range
3.61 - 10.36
Loading...
  • Open5.00
  • Day High5.15
  • Day Low4.52
  • Prev Close4.97
  • 52 Week High10.36
  • 52 Week High Date09/10/21
  • 52 Week Low3.61
  • 52 Week Low Date05/13/21

Key Stats

  • Market Cap32.48M
  • Shares Out6.81M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-20.23

KEY STATS

  • Open5.00
  • Day High5.15
  • Day Low4.52
  • Prev Close4.97
  • 52 Week High10.36
  • 52 Week High Date09/10/21
  • 52 Week Low3.61
  • 52 Week Low Date05/13/21
  • Market Cap32.48M
  • Shares Out6.81M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-20.23

RATIOS/PROFITABILITY

  • EPS (TTM)-1.20
  • P/E (TTM)-3.99
  • Fwd P/E (NTM)-5.18
  • EBITDA (TTM)-7.551M
  • ROE (TTM)-176.36%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,822.00%
  • Debt To Equity (MRQ)2.20%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vallon Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Vallon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is primarily focused on the development and commercialization of proprietary biopharmaceutical products. It is focused on developing prescription drugs for central nervous system (CNS) disorders. Its clinical-stage product is Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), an abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of...
Address
Two Logan Square
100 N. 18Th Street, Suite 300
Philadelphia, PA
19103
United States